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Fine non-biological particles small enough to be suspended in the air are
continually inhaled as we breathe. These particles deposit on airway surfaces
where they are either cleared by airway defences or can remain and affect lung
health. Pollutant particles from vehicles, building processes and mineral and
industrial dusts have the potential to cause both immediate and delayed health
problems. Because of their small size, it has not been possible to non-invasively
examine how individual particles deposit on live airways, or to consider how
they behave on the airway surface after deposition. In this study, synchrotron
phase-contrast X-ray imaging (PCXI) has been utilized to detect and monitor
individual particle deposition. The in vitro detectability of a range of potentially
respirable particulates was ﬁrst determined. Of the particulates tested, only
asbestos, quarry dust, ﬁbreglass and galena (lead sulfate) were visible in vitro.
These particulates were then examined after delivery into the nasal airway of
live anaesthetized mice; all were detectable in vivo but each exhibited different
surface appearances and behaviour along the airway surface. The two ﬁbrous
particulates appeared as agglomerations enveloped by ﬂuid, while the non-
ﬁbrous particulates were present as individual particles. Synchrotron PCXI
provides the unique ability to non-invasively detect and track deposition of
individual particulates in live mouse airways. With further reﬁnement of
particulate sizing and delivery techniques, PCXI should provide a novel
approach for live animal monitoring of airway particulates relevant to lung
health.
Keywords: particles; non-invasive; airway surface; X-ray phase contrast; asbestos; mouse;
detection; X-ray imaging; radiography.
1. Background
Inhalation of pollutant particles starts immediately after birth,
and the type of particles inhaled depends on the surrounding
environment. Children can be unknowingly exposed to a wide
range of potentially harmful particles of varied toxicity,
ranging from established toxins such as asbestos and ﬁbreglass
ﬁbres, lead fumes from smelters and (previously) motor
vehicles, coal and mineral dusts from mines and quarries, to
everyday dusts in the air. The lung size, airway physiology,
breathing patterns and rapid development of young children
signiﬁcantly increases their risk over that of adults experien-
cing the same pollutant particle exposure (Wildhaber, 2006).
Although the eventual effects on lung health from inhaling
some of these particles are well known, particularly for
asbestos (Addison & McConnell, 2008), no studies have
examined the manner in which such particles deposit on
airways, nor their physical behaviour and immediate fate after
contacting the airway surface. Knowledge of particle deposi-
tion behaviour may help reveal factors that inﬂuence retention
and thus the later pathophysiology in the lungs.
The ability of airways to clear inhaled particles via muco-
ciliary transit is a clear diagnostic indicator of airway health.
We are developing methods to monitor mucociliary transit in
mice in vivo to assist in determining the effectiveness of
genetic (Limberis et al., 2002) and other potential therapeutics
in cystic ﬁbrosis airway disease. Although reliable methods for
bulk detection of the clearance of particles in airways exist
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(Grubb et al., 2004; Donaldson et al., 2007; Livraghi & Randell,
2007), respiratory science currently lacks a non-invasive
method of detecting these individual particulates, or tracking
their motion in real time. Knowledge of the behaviour of
deposited particles in animal models may provide clues to the
initiation of animal and human pathophysiology, and thus
suggest potential preventative measures for use in young
children as well as in adults. We therefore utilized novel
synchrotron phase-contrast X-ray imaging (PCXI) to detect
and monitor the deposition and comparative transit behaviour
of representative pollutant particles in live mouse airways.
PCXI utilizes X-ray refraction in addition to conventional
absorption to improve image contrast, and it is particularly
useful for achieving soft tissue contrast where the absorption
differences are small. Tissue boundaries are enhanced by the
phase changes induced by differences in their X-ray refractive
indices, provided the incident beam has sufﬁcient spatial
coherence and the sample-to-detector distance is sufﬁciently
long (Snigirev et al., 1995; Cloetens et al., 1996; Wilkins et al.,
1996). We have already shown the ability of PCXI for non-
invasive airspace imaging in small animals (Parsons et al.,
2008). The aim of this study was to test the capability of PCXI
for non-invasive particulate detection in live mouse airways.
2. Methods
The experiment ﬁrst utilized an in vitro study to determine
which of a range of biologically relevant particulates were
detectable using synchrotron PCXI. For those particles that
were adequately detectable, we then examined their in vivo
behaviour when deposited on live mouse airways.
The experiment was performed on the undulator beamline
BL20XU at the SPring-8 Synchrotron Radiation Facility,
Hyogo, Japan. The imaging hutch was located 245 m from the
storage ring in the Biomedical Imaging Centre, and the
imaging layout was as shown previously (Parsons et al., 2008).
Monochromatic X-rays of 25 keV ( = 0.5 A˚) were selected
using a standard double-crystal monochromator (Yabashi et
al., 1999). At the imaging station the beam size was approxi-
mately 10 mm (H)  6 mm (V) and the incident photon ﬂux
was approximately 4.37  109 photons s1, producing an
estimated dose rate of 0.61 Gy s1. The propagation (sample
to detector) distance was 135 cm, chosen to produce a sufﬁ-
ciently strong bright/dark fringe from each particle, so that
they could be identiﬁed amid intensity variations introduced
by overlying tissue and skin. Images were captured using a
high-resolution X-ray converter (10 mm maximum diameter
ﬁeld of view; AA50 Hamamatsu Photonics) with a charge-
coupled device (CCD) detector. The converter used a 10 mm-
thick scintillator (Lu2SiO5:Ce) to convert X-rays to visible
light, which was then directed to the CCD using a 20 X-ray
converter microscope objective lens with a numerical aperture
of 0.4. The detector was a pco.4000 (PCO Imaging) with an
array size of 4008  2672 pixels and a 9 mm native pixel size.
This set-up resulted in an effective isotropic pixel size of
0.45 mm and a ﬁeld of view of 1.8 mm  1.2 mm. The FWHM
of the point spread function, as determined from a horizontal
edge image, was measured at 3.6 mm. Exposure times between
90 ms and 300 ms were used for the in vitro studies, and 300 ms
for the in vivo studies.
2.1. In vitro studies
A range of potentially respirable pollutant particles were
examined dry or suspended in a carrier ﬂuid (distilled water)
to determine their visibility using PCXI. Chrysotile (white
asbestos), provided by the South Australian Museum, and
ﬁbreglass from a commercial pipe insulation were separately
ground under water to produce ﬁbres suited for examination.
Galena, the natural mineral form of lead sulﬁde (PbS), was
also obtained from the South Australian Museum, and dolo-
mite quarry dust was provided courtesy of the Boral
Resources (SA) Limited Linwood Quarry, Adelaide, South
Australia. Other relevant compounds, tested to conﬁrm, in
part, theoretical limitations in the application of PCXI
imaging, included combusted diesel particles and standard
roadside PM10 ﬁltered particulate matter (provided by Dr I.
Gilmour, USA EPA, Research Triangle, NC, USA), and laser
printer toner (Epson).
All particle samples (except asbestos, see Results) were
sieved using a 25 mm  25 mm oriﬁce stainless-steel mesh; a
small sample was then tapped, puffed or dropped onto the
exposed adhesive surface of short lengths of Kapton tape, a
polyimide ﬁlm highly transparent to X-rays (PC500 1 mm-thick
with 1.5 mm-thick silicon adhesive; Argon Masking Inc.). The
particles were then sealed in place using a second piece of
tape. The samples were mounted on a controllable XY stage in
the hutch for imaging. Comparative images taken under light
microscopy at 400 magniﬁcation were also used to ensure
the regions imaged using PCXI included the particles of
interest.
2.2. In vivo studies
For the in vivo experiments, ten hairless mice (Crlj:CD1-
Foxn1nu) weighing 18–26 g were imaged under approval
from the Animal Ethics Committee of SPring-8 and of the
Children, Youth and Women’s Health Service, Adelaide. Mice
were anaesthetized with Nembutal (45 mg kg1, i.p.) and were
humanely killed via Nembutal overdose (500 mg kg1, i.p.) at
the end of each study without awakening. The anaesthetized
mice were secured on a polyethylene imaging board
containing an open slot to allow the passage of the X-ray beam
directed anterior to posterior along the centre line of the
mouse. The dorsal incisors were hooked over a stainless-steel
wire loop, and the limbs and shoulders, and above and below
the imaging area in the head, were taped to minimize body
movements owing to respiration during imaging. The level of
anaesthesia was monitored by foot pinch and changes in
respiration. Nembutal was continuously infused by a syringe
pump via an indwelling i.p. needle (typically at a rate of
0.9 ml min1), with additional top-up Nembutal injections
given as required.
A small-diameter polyethylene recording cannula, made
from heat-pulled and thinned polyethylene PE10 tubing (Tyco
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Electronics), was placed to a depth of 10 mm in the right
nostril, to provide a route for direct delivery of test particulate
agents suspended in water to the nasal airway. The position of
the cannula tip in the nose was recorded at the end of several
deposition studies by inserting a ﬁne wire, previously aligned
to reach to the end of the cannula tip. The distinctive bone
suture line in the nasopharyngeal airway posterior to the
olfactory region provided an easily locatable landmark near
which the airway imaging was performed (Fig. 2). Nasal
airways in laboratory mice were utilized here since they are
commonly used as a model site for pre-clinical testing of
airway function after gene transfer procedures by our group
(Limberis et al., 2002) and others (Grubb & Boucher, 1999).
The mouse nasal airway is lined with the ciliated respiratory
epithelium which mimics that present in human lung
conducting airways. This region is also well suited to these ﬁrst
live PCXI particulate imaging procedures because the airway
is stable within the head and shows little movement during
breathing; in contrast, lung airways are in almost continuous
motion during breathing.
Images were captured at a rate of 0.2 Hz. After 1 min of
baseline collection, samples of particulates suspended in
distilled water were delivered via the nasal cannula either
manually or using a syringe pump, at volumes between 15 ml
and 50 ml, in one bolus over 10 to 60 s (see Results). Image
collection was continued at 0.2 Hz for a further 19 min,
creating a dataset consisting of 240 images, close to the
maximum number of images (260) the pco.4000 camera’s
onboard memory buffer could record.
The anatomy of the mouse head at the imaging location
introduced confusing detail (from other head structures in the
path of the X-ray beam) into the PCXI images, which could
obscure individual small particles in single images. To facilitate
rapid and accurate location of relevant particles, each image
sequence was analysed with simple motion-detection software
(VirtualDub, Version 1.8.6, Avery Lee, using the MSU Motion
Estimation plug-in, Graphics and Media Lab, Moscow State
University) to reveal where motion was occurring by applying
digital image subtraction and ﬁltering algorithms that identify
regions of the image that change between frames. The output
of this motion-detection software was sequential frames that
were neutral grey where there was no motion detected, and
lighter or darker grey where motion was detected. The dark
outlines corresponded to the most recent position of the
moving object, and the light outlines corresponded to the
position of the object in the previous frame. For high-quality
motion detection the background must remain still compared
with the moving objects to be detected, hence the special
efforts we made to minimize the movement of the mouse
during imaging.
3. Results
3.1. In vitro studies
We ﬁrst tested the range of potential pollutant or toxic
particles encapsulated between adhesive Kapton tape and
examined their detectability under PCXI, prior to use in live
mice. At a propagation distance of 135 cm, many particles
were visible both from phase contrast or absorption, or a
combination of both. For example, galena absorption domi-
nated the image contrast, and thus produced shadows with no
fringes. In contrast, the glass beads refracted the X-rays and
introduced variations in the phase of the X-ray wave across
the width of the object. The interference of the phase-shifted
waves produced light and dark fringes, i.e. phase contrast, but
not a dark shadow where the glass was, since it did not absorb
strongly. Some particles, such as quarry dust, showed both
phase and absorption contrast, appearing darker where the
object attenuated the beam, as well as having some bright/
dark fringes around the edges. The 300 ms exposure length
produced the optimum images, capturing sufﬁcient incident
photons to ﬁll the potential dynamic range (214 grey levels),
thus providing the maximal signal-to-noise ratio without
inducing detector saturation. Fig. 1 shows results of these
in vitro studies, and clearly demonstrates the differences in
detectability between particle types.
Small individual asbestos ﬁbre bundles, ranging in width
from 4 mm to 15 mm and in length from near 25 mm through to
several millimetres, could be seen in the PCXI images (Fig. 1a).
Additionally, many large ﬁbre bundles were also present,
some with widths up to 200 mm, as observed under light
microscopy. Despite extensive manual wet-grinding, asbestos
particles could not be ground and separated into uniform size
fractions. In addition, asbestos ground under water formed an
enmeshed ﬁbrous meshwork that resisted centrifugation
(6500 r.p.m. up to 5 min) or extended ultrasoniﬁcation (up to
10 min) that should have assisted in its preparation into ﬁner
diameter fractions. For safety reasons, in this study we did not
attempt to employ dry grinding to produce smaller dry
asbestos ﬁbres. As a result, the delivery of asbestos was
technically difﬁcult because large ﬁbres could clog the cannula
tip when the ﬂuid dose was drawn into, or ejected from, the
dosing cannula. Thus we relied on settling in water in an
attempt to obtain ﬁner size fractions. Nevertheless, clumps of
ﬁne ﬁbres could still be observed when samples were ejected
onto a clean surface, suggesting that asbestos ﬁbre clumps
could still occur when delivered via a cannula.
Like asbestos, quarry dust was also readily detectable
(phase and absorption contrast) but appeared as compact
irregularly shaped particles primarily between 7 mm and
30 mm. Although particles (apart from asbestos) were sieved
through a 25 mm square stainless-steel mesh, occasional larger
particles (up to 90 mm) were also present (e.g. Fig. 1b) possibly
owing to clumping effects. The quarry dust produced more
image contrast than the asbestos (but signiﬁcantly less than
galena, see below).
Fibreglass was substantially less visible than either asbestos
or quarry dust (phase contrast and absorption). Under PCXI
the ﬁbreglass particles had the same individual ﬁbre/rod
morphology present in light microscopy (Fig. 1c). Most ﬁbres
were between 12 mm and 25 mm in length, but again there were
a small number of ﬁbres with lengths up to 100 mm. Unlike
asbestos ﬁbres there was little variation in ﬁbre width, with all
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visible ﬁbres approximately 8 mm wide. Similar to asbestos,
ﬁbreglass ﬁbres used here were normally longer than 100 mm,
but unlike asbestos the grinding process was effective for
reducing the length of the ﬁbres. We did not observe an
enmeshed network when examining the ﬁbreglass samples and
there was no difﬁculty drawing or expelling the ﬁbreglass
samples in solution via the thin cannula.
Samples containing lead were obtained by grinding galena
(PbS). Not surprisingly, these particles were easily detected
under PCXI, primarily via absorption, and appeared similar to
images obtained under light microscopy (Fig. 1d). The galena
particles ranged in size from 10 mm up to 30 mm, and in
comparison with the quarry dust they were denser, more
uniform in shape, and were less varied in size. Since all
samples were prepared as a percentage w/v, the galena
samples contained fewer particles per volume owing to the
higher density of the mineral; nevertheless, there were sufﬁ-
cient particles present for in vitro detection.
We have routinely employed silver-
coated hollow glass beads as PCXI
markers (Fig. 1e) because the air within
the bead provides good visibility under
PCXI. This is due to the enhanced
phase-contrast effect from the high-
refractive-index gradient across the
glass–air boundary, despite the material
producing little absorption. In both the
PCXI and light microscopy images
the beads were easily detected, with
diameters varying between 12 mm and
25 mm despite the stated nominal
diameter being 14 mm. Under light
microscopy all the beads appeared solid,
because the silver coating makes them
opaque to visible light. However, under
PCXI most beads appeared hollow
because the air within them refracted
the X-ray beam so that they showed up
more clearly with phase contrast. Some
of the smaller beads present were not
hollow, and so produced little phase
contrast.
At the completion of the in vitro
testing, ﬁve particle types were consid-
ered sufﬁciently visible to warrant study
in vivo. Not all particles detected in
vitro were suitable because the mouse
head structures surrounding the airway
being imaged would obscure particu-
lates that were poorly visible in vitro.
For in vivo study we selected the ﬁbrous
particulates asbestos and ﬁbreglass, and
the non-ﬁbrous quarry dust and galena.
We also used silver-coated hollow glass
beads as reference particles. The largely
carbon-based particulates, combusted
diesel, PM10 and laser printer toner,
were not sufﬁciently visible to warrant in vivo testing.
3.2. In vivo studies
3.2.1. Site of particulate delivery in mouse airway. The
10 mm delivery depth of the nasal airway cannula placed the
tip just anterior to the origin of the nasopharyngeal airway
(Fig. 2). This location was approximately 5.5 mm anterior to
our standard nasopharyngeal imaging region near the skull-
bone suture line (Parsons et al., 2008) that is readily located in
each animal.
3.2.2. Determination of dosing protocol. Based on the
in vitro studies, an initial testing protocol for use in live mice
was created to achieve maximal use of each mouse and the
limited beam time available. After a brief baseline imaging
period (no treatment), each animal received one of the ﬁbrous
particle instillations (either asbestos or ﬁbreglass), along
with the reference hollow glass beads. The instillation was
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Figure 1
In vitro dry particulate testing revealed the particulates that were visible using PCXI. Samples were
examined under PCXI (main pictures) and light microscope (insets): (a) asbestos, (b) quarry dust,
(c) ﬁbreglass, (d) galena and (e) silver-coated hollow glass beads. The morphology of each of the
particulates is clearly very different. For layout and presentation purposes, and so they are at the
same level of magniﬁcation, the PCXI images are cropped to 0.90 mm  0.60 mm, and the light
microscope images are 0.365 mm  0.27 mm.
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performed remotely over 60 s using a syringe pump (dose
volumes as determined below). Approximately 25 min later
one of the non-ﬁbrous particulates (either galena or quarry
dust) was delivered manually over 10 s; manual solution
changes required opening of the imaging hutch for physical
access to the instillation syringe by the experimenter. This
protocol ensured that all particulates could be tested using a
small number of mice, while the simultaneous delivery of the
control particles (glass beads) was used to conﬁrm that
successful instillation had occurred.
3.2.3. Effect of particulate delivery volume, rate and
concentration. Based on the overall particulate density seen
in the in vitro PCXI images, concentrations of 0.5% w/v for
ﬁbreglass and asbestos (mixed with 0.5% w/v reference glass
beads) and 0.1% for galena and quarry dust were chosen,
to provide a sufﬁcient quantity of particulates to be visible
in vivo, but to limit the possibility of cannula or airway
blockage during deposition.
Initially the volume was set at 50 ml delivered over 10 s,
replicating the tolerable dose volume typically used when
dosing the mouse lung via the nasal airway. This combination
was tested in one mouse. Fluid and particles were detected
immediately after dose delivery began. However, the 50 ml
volume produced a period of cough-like respiratory excur-
sions that, while small and transient, caused sufﬁcient body
movement to produce blurring of some captured images.
These factors suggested that smaller doses delivered over a
longer period should be trialled to minimize movements
caused by the dosing protocol, while retaining the ability to
detect particles in the nasal airway.
Accordingly, the dose volume was progressively reduced in
two subsequent mice. We found that a 15 ml dose volume
provided sufﬁcient visible ﬂuid and particulates to be moni-
tored in the nasal airway, but induced only a brief increase
(< 1 min) in respiratory effort. Importantly, subsequent dosing
in the same animal was also well tolerated with this dose
volume. For the ﬁbrous particulates the 15 ml dose was deliv-
ered by syringe pump over a period of 60 s, commencing after
the initial 60 s of baseline imaging. As the galena and quarry
dust particles settled more rapidly, these were manually
instilled over a period of approximately 10 s. This protocol was
used for the seven remaining animals.
3.2.4. Particulate detection. Using the motion-detection
software all ﬁve particulates could be detected in vivo,
although with different degrees of visibility and with varying
levels of difﬁculty. On the airway surface the ﬁbrous particu-
lates were surrounded with ﬂuid; since this was of similar
refractive index to these particles it resulted in a reduction in
phase contrast and a loss of particle visibility within the ﬂuid
envelope. Thus in vivo detection of all particles (other than the
hollow glass beads) was more reliant on absorption contrast
than phase contrast.
For both ﬁbrous particles an initial bulk liquid dose moved
past the imaging site within approximately 90 s after the start
of dose delivery. The rapid movement coupled with relatively
long exposure times meant that we could not determine
whether particulates were contained within the moving liquid.
Because the heavier non-ﬁbrous particulates (galena and
quarry dust) were delivered manually and there was a delay
(typically 1 min) between particulate delivery and imaging,
during which the beamline hutch was closed and the X-ray
shutter was opened, we were unable to determine whether an
initial bulk movement of the dose liquid was present imme-
diately after delivery.
Compared with the number and size of the particulates
detected in vitro (Fig. 1), very few large particulates were seen
in vivo (Figs. 3–7). Large particles that were detected took
longer to appear at the imaging site than the small particulates.
Additionally, in some animals asbestos ﬁbres took 4 to 5 min
to appear. In comparison, all other particulates appeared
within 1 min of commencing instillation (or as soon as imaging
could be started in the case of the galena and quarry dust).
The rate at which the different particulate types moved
along the airway varied widely, between 0.1 mm min1 and
4.4 mm min1. When examining the non-ﬁbrous particulates, a
small number of ﬁbrous particulates from the ﬁrst part of the
dosing protocol 30 min beforehand continued to move past
the imaging site. However, the different appearance of each
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Figure 2
Amontage of 13 individual adjacent and offset PCXI images showing the
cannula position and the imaging location (white square), overlaid on a
larger general PCXI image of the whole mouse skull (taken from Parsons
et al., 2008). The ﬁne-gauge wire reaching to the cannula tip is apparent
(the cannula itself cannot be discerned at this magniﬁcation). As shown
here, the tip is located at the rear of the olfactory region. The plastic
restraint board used in these latter studies included a cut-out region; the
curved edge of this opening is noted. For additional anatomical
landmarks, see Parsons et al. (2008).
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particle type in the airway ensured that they could still be
differentiated.
3.2.5. Appearance of particulates in live mouse airway.
Asbestos. Fig. 3 shows the appearance of asbestos ﬁbres as
revealed using the motion-detection software (see Methods).
In this and all other in vivo images presented here, the ﬁrst
frame is the raw PCXI image and the second is its corre-
sponding motion-detected frame. On the right are the next
two motion-detected frames captured 5 s and 10 s, respec-
tively, after the original frame. Interestingly, the third pane in
Fig. 3 shows more background detail because a slight move-
ment of the mouse head was picked up by the motion detec-
tion. Unlike in the in vitro study, individual asbestos ﬁbres
were not detected, but appeared as agglomerations of en-
meshed ﬁbres trapped in liquid. The enveloped structure
could be seen moving along the airway. We noted that there
were few of these agglomerations present, but where detected
they were large compared with the sizes of the individual
ﬁbres, in some cases up to 1 mm in length. These structures
moved more rapidly in vivo than the other particulates. The
sequence in Fig. 3 shows the unusual shape of these airway
surface structures which often possessed a ‘tail’ that trailed
behind the ﬂuid envelope.
Quarry dust. The quarry dust was also readily detectable
in vivo (Fig. 4) where it appeared as compact and irregularly
shaped particles. The smallest detectable dust particles were
approximately 10 mm, but, unlike in the in vitro study where
large particles up to 90 mm diameter were present, most in vivo
particles were smaller, less than 50 mm. While the quarry
dust particles produced a greater image contrast than that
seen with asbestos, there was no appearance of aggregation;
the dust was only present as individual particles and did not
show a ﬂuid envelope when detected on the airway surface.
Fibreglass. Although ﬁbreglass was substantially less visible
than either asbestos or quarry dust in vitro, it was readily
detectable in vivo (see Fig. 5). Fibreglass ﬁbres displayed the
smooth, enveloped, but irregularly shaped form similar to that
seen with asbestos. Individual ﬁbres were generally not visible,
thus we could not determine a minimum detection size. These
enveloped ﬁbreglass shapes moved at approximately one
tenth of the rate of the larger asbestos objects.
Galena (PbS). Despite its high density, galena was difﬁcult
to detect in vivo. The particles were smaller than quarry dust
and did not provide strong phase contrast (i.e. detection
appeared to be via absorption only) (Fig. 6).
Hollow glass beads. As noted above, the air contained
within these small beads enhanced their visibility owing to
phase contrast. When delivered concurrently with the ﬁbrous
particulates they were visible (albeit sometimes in low
numbers) in many images (Fig. 7). Like galena and quarry
dust, the hollow glass beads appeared as individual particles
and their appearance did not indicate that a liquid envelope
was present whilst moving along the airway surface.
4. Discussion
The primary goal of this study was to determine whether the
refractive (phase) and absorption characteristics of common
pollutant particles permitted their detection in live mouse
airways using synchrotron PCXI. The in vitro results showed
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Figure 3
Asbestos particulate detection. The two panes on the left show the original PCXI image and its corresponding motion-detected frame that revealed the
moving object on the airway. The panes on the right are the next two motion-detected frames in the sequence. The black arrows mark the nasal airway
edge running vertically through the image, and the white lines follow the same object across the three sequential frames each separated by 5 s. The last
frame shows an enveloped clump of ﬁbres with an elongated tail. These enveloped structures moved along the airway faster than all other particles
studied, here at a rate of 4.4 mm min1.
Figure 4
Four particles of quarry dust are visible at the centre of the motion-detected frames. Particles did not aggregate or have the appearance of trapping liquid
around them on the airway surface. In this sequence the quarry dust particles are moving at a rate of 0.41 mm min1.
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that the PCXI technology was well suited to the detection of
asbestos, quarry dust, ﬁbreglass and galena as raw particulates.
To our knowledge this is the ﬁrst report of the ability to
detect and monitor the surface behaviour of these pollutant
particles, non-invasively, in live airways. This capability is
signiﬁcant because PCXI has the unique ability to image the
initial deposition, airway surface appearance, and the move-
ment characteristics of individual particulates on an intact live
airway surface. Furthermore, this approach has provided new
information about the behaviour of individual particles of
potential signiﬁcance in studying respiratory disease from the
earliest points of interaction in the airway, at times far earlier
than previously possible.
Our ability to use in vivo PCXI imaging during the actual
instillations of particulates, via a remote-controlled syringe
pump, demonstrated that a volume of 15 ml was sufﬁcient to
produce detectable particulates in the nasal airway, and that
this dose setting ensured there were minimal respiratory side
effects able to cause movements that blurred subsequent
image captures. These side effects may have been greater than
normal because mice were imaged in a vertical orientation,
whereas mice are normally studied supine or prone when
anaesthetized in biomedical studies. Gravity may also have
impeded clearance of instilled ﬂuid that reached the lung,
causing higher than normal cough and respiratory excursions.
In general, there were smaller numbers of particulates
detected than expected, given the concentration and volume
delivered. Some of the delivered volume may have been
trapped in the tortuous olfactory passages present in mice, and
it is not possible to know the exact location of the cannula tip
in this complex organ [see Mery et al. (1994) for anatomical
details] when introduced via the nose (Parsons et al., 2008).
More frequent detection of particulates could occur if the
particle concentration was higher, especially for galena and
quarry dust. However, 0.1% w/v is the common standard dose
concentration for ﬂuid-based instillations in mouse models,
when testing the effects of atmospheric particulates on airway
and lung health (I. Gilmour, personal communication).
Accordingly, use of higher particle concentrations [as a
percentage (w/v)] would not align with accepted practice. We
believe that better targeting of cannula tip, conﬁrmed by
placement via orthogonal imaging at the commencement of
PCXI studies, will improve nasal as well as lung delivery when
using small dose volumes.
Although individual asbestos and ﬁbreglass ﬁbres were not
visible in vivo, both ﬁbres appeared to attract a liquid
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Figure 5
Fibreglass appears similar to asbestos, but the objects were smaller and had shorter tails. Like asbestos, the ﬁbres appeared to smoothly trap liquid
around them so that individual ﬁbreglass ﬁbres could not be seen. Fibreglass moved at the same speed as the quarry dust, at 0.41 mm min1.
Figure 6
Galena particles were the most difﬁcult to locate in the in vivo PCXI images, and also moved the slowest, at 0.1 mm min1.
Figure 7
Reference hollow glass beads. In this animal, beads are located in the nasal airway, but also in the mouth (black arrow to the right of the right-hand-side
airway edge). The glass beads moved in the nasal airway at 0.3 mm min1.
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envelope around them when observed on the airway surface.
In contrast, galena and quarry dust remained visible as indi-
vidual particles. The ﬁbreglass particle agglomerates were
smaller than for asbestos, presumably owing to the much
shorter particle lengths created by the grinding process.
Asbestos ﬁbres naturally aggregate through hydrogen
bonding, depending on the relative exposure of their hydr-
oxylated surfaces, either in the natural mineral or after
extended exposure to water (Healey & Young, 1954; Pund-
sack, 1955). Our inability to grind the asbestos under water
(Papirer & Roland, 1981) to produce uniform suspensions of
smaller ﬁbres supports this interpretation. In this setting we
interpret the objects found transiting the airway surface after
dosing as enmeshed asbestos ﬁbre clumps enveloped with
ﬂuid, and this interpretation is supported by the similar
structures present after ﬁbreglass ﬁbre delivery. Furthermore,
both types of ﬁbres clumped such that in many cases an
enclosed ‘tail’ followed behind the direction of movement of
the object. Although we could not detect individual ﬁbres
within these objects, it seems likely that these tails contained
ﬁbres that extended behind the core meshed clump of ﬁbres as
it moved along the airway surface.
Since we never observed individual asbestos ﬁbres on the
airway we could not determine the size of the delivered ﬁbres
or the minimum size of asbestos ﬁbres that were detectable
in vivo via PCXI. The high rate of movement of these objects,
much larger than both the similar ﬁbreglass-based objects and
the other individual particles, raises the possibility that airways
deal with the deposition and transport of ﬁbre-based particles
on live airway surfaces via a fundamentally different
mechanism to that underlying deposition of non-ﬁbrous
particles like dust and galena. Inhalation of asbestos can have
devastating health consequences on lung health, and further
study of the way that airways handle such ﬁbres when they are
ﬁrst encountered may provide new insights into the earliest
pathophysiological components of asbestos lung disease.
Galena was difﬁcult to detect in vivo despite its high density
because it was the smallest of all the particles, and there were
fewer particles present (on a w/v basis). We also noted that
galena particulates rapidly settled out of the delivery ﬂuid,
reducing the delivery effectiveness from the dosing cannula. In
addition, because of the imaging delay after manual instilla-
tion and the upright orientation of the mouse, some of the
heavier particulates may have already passed the imaging site
by the time imaging commenced, especially if carried within a
large initial bolus that would likely have been produced by
delivery over the shorter instillation time of 10 s. Smaller
galena particles could also be mistaken for the small dark
spots present in baseline images and probably caused by
individual or overlaid phase-contrast edge-enhancement
effects derived from the various skull-bone ﬁne structure
encountered by the X-ray beam as it transits the head.
Accordingly, we propose that it is essential to analyse these
image sequences using motion-detection routines so that only
moving particles were detected. Galena also produced little
phase contrast and it did not trap an envelope of liquid around
it. We speculate that the absence of a liquid layer around the
galena, quarry dust and glass beads could also in part be due
to the interaction between their shape and the local surface
tension environment on the airway surface.
To our knowledge this is the ﬁrst study to examine PCXI
detection of individual particles in vivo, and there are a
number of limitations inherent in the techniques and the
interpretation of the results we have provided. While our
ﬁndings are novel, use particles relevant to respiratory health
(excluding the reference hollow glass beads) and show the
potential of PCXI for studying live mouse airways, the nature
and controllability of the particulate doses is not yet optimal,
and the normal exposure and uptake of those particulates is
quite different.
Firstly, the effective (aerodynamic) diameter of inhaled
particulates must be less than approximately 10 mm to be
capable of inhalation past the oropharynx, into the lung of
humans. Fibres and particles below approximately 1–2 mm in
diameter can be inhaled into the deepest parts of the lungs
(Miserocchi et al., 2008) while larger sizes such as the >7 mm
ﬁbres we examined in vitro would contact the conducting-
airway walls and be removed by mucociliary clearance and
coughing. An improvement in the minimum size detectable
under PCXI will be important for ensuring biological rele-
vance in future instillation or inhalation studies, especially
with the growing awareness of the importance of ultraﬁne
(<2.5 mm diameter) particles. Secondly, the lead-containing
particles were ground galena which is a form of lead different
to that inhaled as lead fumes (e.g. lead sulfates or oxides) from
a lead smelter or in leaded petrol. Finally, for ﬁbreglass there
are many forms and uses of this ﬁbre, and the type of ﬁbreglass
we used (from pipe lagging) may not be representative of that
producing exposure at health-affecting levels in industrial or
residential settings.
Although convenient experimentally, delivering particles
into mouse airways within a distilled water bolus is not usual
in life; inhalation as an aerosol or a dry powder is more
physiologically relevant, and planned studies will examine this
particle delivery approach. The methodology we used, though
effective, also warrants improvement if PCXI is to become a
useful technique in respiratory research. While the skull-bone
suture line is easy to locate in the mouse nasal airway and
produces a repeatable and stable imaging location under
PCXI, we are now examining effects in lung airways since this
is the relevant target organ.
Despite some difﬁculty detecting and tracking particles in
the raw image sequences, moving particulates could be readily
revealed using motion-detection processing. Unfortunately
motion-detection analysis is not suited to detecting stationary
particles. However, from our experience we propose that such
analysis will be essential when performing such in vivo non-
invasive studies of airway particulate deposition.
In these ﬁrst studies little effort was made to limit radiation
dose, which was too intense to consider animal recovery
and repeated imaging. The current rapid development of
synchrotron and imaging technology suggests there will
continue to be improvements in CCD sensor technology, and
analytical techniques such as motion detection and particle
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tracking. Combined, they should lead to improved image
resolution and higher light sensitivity, allowing smaller, and
therefore more physiologically relevant, particulates to be
detected and tracked. Minimizing tissue motion via combined
respiratory and cardiac gating (Sera et al., 2008) will reduce
blurring and motion artefacts and result in more usable
images. These gradual improvements should result in better
particulate visualization to permit deposition and detection of
smaller particulates, as well as shorter exposure times that
both minimize motion artefact and produce essential reduc-
tions in radiation dose. However, despite these needs for
improvement there are no imaging alternatives that can non-
invasively detect and track such small and individual particles
or ﬁbre clusters in vivo, and these PCXI techniques should
provide a novel addition to the imaging tools available for use
in live airways.
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